Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT07455760

Investigating Subcortical Contributions to Speech Sequencing in Deep Brain Stimulator Recipients

Led by Boston University Charles River Campus · Updated on 2026-03-09

80

Participants Needed

2

Research Sites

232 weeks

Total Duration

On this page

Sponsors

B

Boston University Charles River Campus

Lead Sponsor

N

National Institute on Deafness and Other Communication Disorders (NIDCD)

Collaborating Sponsor

AI-Summary

What this Trial Is About

This study will examine how two important brain circuits - one involving the subthalamic nucleus (STN) and one involving the ventral intermediate nucleus of the thalamus (VIM) - contribute to learning and producing speech sequences. Participants will include two groups: 1. individuals with Parkinson's disease who have deep brain stimulation (DBS) devices targeting the STN and 2. individuals with essential tremor who have DBS devices targeting the VIM. Participants will complete speech tasks involving the learning and repetition of novel sound sequences. During some parts of the study, DBS stimulation will be temporarily turned on or off in a controlled research setting. This will allow researchers to examine how stimulation affects both the learning of new speech sequences and the production of previously learned sequences. All STN participants and most VIM participants will also be equipped with a cutting-edge DBS system, the Percept PC, which will enable the recording of deep brain activity during the tasks. The results of this study will improve our understanding of how different brain circuits support speech learning and production. In particular, this study will help to differentiate the roles of the STN and VIM in learning the ordering of speech sounds within a syllable from learning of speech sequences containing multiple syllables. This knowledge may help guide future approaches to optimizing DBS settings to improve both movement and speech outcomes in individuals with neurological disorders, as well as provide greater general insight into how these brain structures contribute to speech production and learning.

CONDITIONS

Official Title

Investigating Subcortical Contributions to Speech Sequencing in Deep Brain Stimulator Recipients

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Native speakers of American English
  • Adults at least 18 years of age
  • Clinically diagnosed with Parkinson's disease or essential tremor
  • Able to provide informed consent
  • Treated with DBS targeting the subthalamic nucleus (Parkinson's) or ventral intermediate nucleus of the thalamus (essential tremor)
  • Stable medication regimen for Parkinson's disease or essential tremor for at least one month
  • Stable DBS program settings for at least one month
  • DBS system functioning normally with adequate battery or charging status
  • Implanted with Medtronic Percept PC or Percept RC device for DBS sensing
  • Corrected vision sufficient to read text during speech tasks
Not Eligible

You will not qualify if you...

  • Cognitive impairment with MoCA score below 25 or active psychotic/behavioral symptoms preventing participation
  • Hearing impairment that interferes with perception of speech learning stimuli
  • Language or speech articulation impairments preventing speech motor learning task performance
  • Neurological disorders interfering with speech motor learning
  • Inability to tolerate symptoms when DBS is turned off
  • Oral structural issues like orthodontia or cleft palate that affect speech
  • Pregnancy
  • For the sub-syllabic sequence study, prior experience with Hebrew, Polish, Lithuanian, Romanian, Georgian, Tepehua, Hungarian, or Pima languages

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Boston University

Boston, Massachusetts, United States, 02215

Actively Recruiting

2

Massachusetts General Hospital

Boston, Massachusetts, United States, 02215

Actively Recruiting

Loading map...

Research Team

F

Frank H Guenther, Ph.D.

CONTACT

B

Barbara G Holland, MA

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

PARALLEL

Primary Purpose

BASIC_SCIENCE

Number of Arms

4

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here